Traditional treatment methods for hyperlipidemia often face challenges such as poor drug solubility, low bioavailability and off-target effects. At Creative Biolabs, we leverage our expertise in lipid chemistry and drug delivery principles to develop advanced lipid-based drug delivery systems that can overcome these obstacles.
Hyperlipidemia is a disease caused by lipid metabolism disorders, leading to elevated levels of lipids in the blood. From an epidemiological perspective, hyperlipidemia is a widespread condition with increasing prevalence globally, posing a substantial public health burden. Current treatment difficulties stem from the varying effectiveness of traditional therapies in achieving optimal lipid levels for all patients, along with potential side effects. Generally, if the total cholesterol (TC), triglycerides, or low-density lipoprotein-cholesterol (LDL-C) in the serum is too high, or the high-density lipoprotein-cholesterol (HDL-C) is too low, it can be defined as hyperlipidemia. It can lead to atherosclerosis and may also induce coronary heart disease, myocardial infarction, and stroke.
Lipid-based drug delivery systems offer a promising solution to overcome the limitations of traditional hyperlipidemia treatments. These systems can encapsulate a variety of therapeutic agents, including small molecules, proteins/peptides, and nucleic acids, enhancing their solubility and bioavailability. By protecting the active ingredients from degradation in the gastrointestinal tract and enabling controlled release, lipid-based drug delivery systems ensure that the drugs reach their target sites in effective concentrations.
Fig. 1 Peptides inhibit the synthesis of cholesterol.1
Creative Biolabs provides comprehensive lipid-based drug delivery solutions to support your hyperlipidemia research.
We can encapsulate various drugs for hyperlipidemia through multiple lipid-based drug delivery systems, such as statins, fibrates, and niacin. If you need to deliver multiple drugs simultaneously, we can also provide professional solutions.
Drug | Mechanism | Inquiry |
---|---|---|
Statins | Block cholesterol synthesis | Inquiry |
Bile acids | Bind with cholesterol | Inquiry |
Cholesterol absorption inhibitors | Block absorption | Inquiry |
Fibrates | Decreasing production of very low-density lipoprotein (VLDL) and clearing triglycerides | Inquiry |
Nicotinic acid | Antilipolytic effect | Inquiry |
Creative Biolabs' lipid-based delivery systems can enhance the stability and bioavailability of these peptides, ensuring they reach their target sites effectively and exert their therapeutic effects. We offer a full range of services for the development of anti-hyperlipidemia peptide-based therapies.
mRNA therapy is a promising approach for hyperlipidemia treatment. It involves delivering mRNA molecules that encode proteins or enzymes involved in lipid metabolism regulation. Once inside the target cells, the mRNA is translated into functional proteins, which can help restore normal lipid metabolism and reduce lipid levels in the blood. Creative Biolabs offers a variety of mRNA-LNP products and also provides LNP customization services.
By choosing Creative Biolabs, you gain access to our extensive expertise and state-of-the-art facilities, ensuring that your research project progresses smoothly from concept to validation.
Creative Biolabs' lipid-based drug delivery systems are transforming hyperlipidemia treatment by improving drug delivery, enhancing therapeutic efficacy, and minimizing side effects. Our innovative solutions and expertise make us an ideal partner for pharmaceutical companies and research institutions. If you're interested in exploring how our lipid-based delivery solutions can benefit your hyperlipidemia project, please don't hesitate to contact us.
Reference
Applications
Online Inquiry